GRANAHAN INVESTMENT MANAGEMENT, LLC Revance Therapeutics, Inc. Transaction History

GRANAHAN INVESTMENT MANAGEMENT, LLC portfolio value:

$6.61M
portfolio value

GRANAHAN INVESTMENT MANAGEMENT, LLC quarter portfolio value change:

+95.37%
quarter

Revance Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +9.52% 21.28K shares 3.52M $27 244.91K
Q2 2022 share Increase +38.30% 61.93K shares -62K $13.82 223.63K
Q1 2022 share Decrease -25.31% -54.80K shares -380K $19.5 161.69K
Q4 2021 share Increase +68.82% 88.25K shares -40K $16.49 216.49K
Q3 2021 share Increase 0.00% 128.23K shares 3.57M $27.86 128.23K